The U.S. Food and Drug Administration (FDA) “encourages diverse patients to participate in medical device clinical trials,” the agency says in part of a new series of videos released to the public this week (November 23). Diversity “can help inform the safe and effective use of these medical products for the diverse population of […]
“We recognize that achieving clinical trials that include diverse populations presents an ongoing challenge,” the PhRMA trade association says in a recent addition to its white paper on Principles on Conduct of Clinical Trials and Communication of Clinical Trial Results. In October, PhRMA’s board approved a new section called Commitment to Enhancing Diversity in […]
The U.S. Food and Drug Administration (FDA) drug and biological product centers intend, to the extent appropriate and permitted by law, to publicly post their reviews of the scientific data and information supporting the issuance, revision, or revocation of Emergency Use Authorizations (EUAs) for all drug and biological products, including vaccines, as part of the […]
Exciting news about potential COVID-19 vaccines in recent days serves as a reminder of how admirably the clinical trial industry has risen to the challenge of battling a worldwide health crisis. From rolling up collective sleeves and putting in long hours of research, to being open to new ways of conducting trials and harnessing technologies, […]
It’s looking more and more like the so-called “COVID catalyst” inspiring faster adoption of technology and virtual components in clinical trials is the real deal. The latest evidence: a new analysis by the Tufts Center for the Study of Drug Development (CSDD). Noting that 55% of active ongoing clinical trials have transitioned to remote […]
